These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30958347)

  • 1. Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer's Disease Are Associated with Oxidative Stress Regulation Mechanisms.
    Patrick S; Corrigan R; Grizzanti J; Mey M; Blair J; Pallas M; Camins A; Lee HG; Casadesus G
    J Alzheimers Dis; 2019; 69(1):157-168. PubMed ID: 30958347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.
    Adler BL; Yarchoan M; Hwang HM; Louneva N; Blair JA; Palm R; Smith MA; Lee HG; Arnold SE; Casadesus G
    Neurobiol Aging; 2014 Apr; 35(4):793-801. PubMed ID: 24239383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease.
    Zhu H; Wang X; Wallack M; Li H; Carreras I; Dedeoglu A; Hur JY; Zheng H; Li H; Fine R; Mwamburi M; Sun X; Kowall N; Stern RA; Qiu WQ
    Mol Psychiatry; 2015 Feb; 20(2):252-62. PubMed ID: 24614496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease.
    Zhu H; Xue X; Wang E; Wallack M; Na H; Hooker JM; Kowall N; Tao Q; Stein TD; Wolozin B; Qiu WQ
    Neuropharmacology; 2017 Jun; 119():170-181. PubMed ID: 28363773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Corrigan RR; Labrador L; Grizzanti J; Mey M; Piontkivska H; Casadesús G
    J Alzheimers Dis; 2023; 91(4):1495-1514. PubMed ID: 36641678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition.
    Grizzanti J; Corrigan R; Casadesus G
    J Alzheimers Dis; 2018; 66(1):11-23. PubMed ID: 30282360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts.
    Mousa YM; Abdallah IM; Hwang M; Martin DR; Kaddoumi A
    Sci Rep; 2020 Feb; 10(1):3751. PubMed ID: 32111883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bajijiasu Ameliorates β-Amyloid-Triggered Endoplasmic Reticulum Stress and Related Pathologies in an Alzheimer's Disease Model.
    Xu TT; Zhang Y; He JY; Luo D; Luo Y; Wang YJ; Liu W; Wu J; Zhao W; Fang J; Guan L; Huang S; Wang H; Lin L; Zhang SJ; Wang Q
    Cell Physiol Biochem; 2018; 46(1):107-117. PubMed ID: 29587274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
    Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
    Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
    Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
    Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice.
    Zhou Y; Xie N; Li L; Zou Y; Zhang X; Dong M
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):635-44. PubMed ID: 24345484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
    Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
    CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.
    Salles GN; Calió ML; Hölscher C; Pacheco-Soares C; Porcionatto M; Lobo AO
    Neuropharmacology; 2020 Jan; 162():107813. PubMed ID: 31628935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer's Disease.
    Wang ZJ; Zhao F; Wang CF; Zhang XM; Xiao Y; Zhou F; Wu MN; Zhang J; Qi JS; Yang W
    J Alzheimers Dis; 2019; 72(4):1217-1231. PubMed ID: 31683484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury.
    Sompol P; Ittarat W; Tangpong J; Chen Y; Doubinskaia I; Batinic-Haberle I; Abdul HM; Butterfield DA; St Clair DK
    Neuroscience; 2008 Apr; 153(1):120-30. PubMed ID: 18353561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
    Cai Z; Wang C; He W; Chen Y
    Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Amylin Against Amyloid-β-Induced Tauopathy and Synapse Loss in Primary Neurons.
    Gan Q; Yao H; Na H; Ballance H; Tao Q; Leung L; Tian H; Zhu H; Wolozin B; Qiu WQ
    J Alzheimers Dis; 2019; 70(4):1025-1040. PubMed ID: 31306122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.